ReviewNaunyn-Schmiedeberg's archives of pharmacology2024

Efficacy and safety of Ruxolitinib, Crisaborole, and Tapinarof for mild-to-moderate atopic dermatitis: a Bayesian network analysis of RCTs.

Xue-Chen Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.